PROGNOSTIC VALUE OF MICROVASCULAR AND PERINEURAL INVASION IN PATIENTS WITH PROSTATE CANCER PT1-4N0-1M0 WHO UNDERWENT RADICAL PROSTATECTOMY
Oncourology
View Archive InfoField | Value | |
Title |
PROGNOSTIC VALUE OF MICROVASCULAR AND PERINEURAL INVASION IN PATIENTS WITH PROSTATE CANCER PT1-4N0-1M0 WHO UNDERWENT RADICAL PROSTATECTOMY
ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ ПЕРИНЕВРАЛЬНОЙ И АНГИОЛИМФАТИЧЕСКОЙ ИНВАЗИИ У БОЛЬНЫХ РАКОМ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ PT1-4N0-1M0, ПОДВЕРГНУТЫХ РАДИКАЛЬНОЙ ПРОСТАТЭКТОМИИ |
|
Creator |
V. Matveev B.; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
M. Volkova I.; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow A. Mitin A.; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow V. Ermilova D.; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow В. Матвеев Б.; ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва М. Волкова И.; ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва А. Митин А.; ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва В. Ермилова Д.; ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва |
|
Subject |
prostate cancer; radical prostatectomy; perineural and microvascular invasion; recurrence development; overall and specific survival
— |
|
Description |
Objective: to evaluate the prognostic value of microvascular and perineural invasion on radical prostatectomy specimens in prostate cancer patients. Subjects: 144 patients with prostate cancer pT1-4N0-1M0 underwent radical prostatectomy at the Cancer Center in 1997 to 2008. The median age was 60.06.4 (43-73) years. The median preoperative PSA level was 10.413.7 (0.8-95.7) ng/ml (PSA<10 ng/ml; n = 67 (46.5%), PSA ≥10 ng/ml; n = 77 (53.5%). Histological study verified adenocarcinoma in all specimens. The median Gleason score was 6.01.4 (Gleason score <7; n = 112 (77.8%), Gleason score ≥7; n = 32 (22.2%)). Extracapsular tumor extension was revealed in 47 (32.6%), seminal vesicle invasion in 13 (9.0%), regional lymph node metastases in 9 (6.3%), positive margin in 9 (6.3%), microvascular invasion in 58 (40.3%), perineural invasion in 61 (42.4%) of the 144 cases. The median follow-up was 36.615.2 months. Results: microvascular invasion was associated with an increase of Gleason score≥7 rate from 15.1 to 32.8% (p=0.015), extracapsular extension rate from 17.4 to 55.2% (p<0.0001), seminal vesicle invasion rate from 1.2 to 20.7% (p<0.0001) and category N+ rate from 3.5 to 10.3% (p=0.095). Perineural invasion was associated with an increase of extracapsular extension rate from 19.3 to 50.8% (p<0.0001) and seminal vesicle invasion rate from 0.0 to 21.3% (p<0.0001). Microvascular and perineural invasion did not influence positive margin rate (p>0.05). Prostate cancer recurrence developed in 19 (13.2%) of the 144 patients. Relapses were registered more frequently in patients with microvascular (from 8.1 to 20.7% respectively, p=0.028) and perineural (from 8.4 to 19.7% respectively; p=0.043) invasion. Five-year overall, specific and PSA recurrence-free survival in a group of 144 patients was 97.6, 98.3, and 82.1%, respectively. Microvascular invasion significantly decreased 5-year PSA recurrence-free survival from 90.0 to 66.8% (p=0.050), but this difference did not translate into a statistically significant reduction in overall (98.8 and 96.0%, respectively, p=0.812) and specific (100.0 and 96.0% respectively, p=0.251) survival. Perineural invasion was associated with a significant decrease in 5-year PSA recurrence-free survival from 92.4 to 68.2% (p=0.045). Overall (100.0% and 94.1% respectively, p=0.090) and specific (100.0% and 95.7% respectively, p=0.217) survival differences between the groups without and with perineural invasion did not reach statistical significance. Conclusion: microvascular and perineural invasion is associated with the worst pathological findings in prostatectomy specimens, higher recurrence rate and lower PSA recurrence-free survival in patients with prostate cancer pT1-4N0-1M0.
Objective: to evaluate the prognostic value of microvascular and perineural invasion on radical prostatectomy specimens in prostate cancer patients. Subjects: 144 patients with prostate cancer pT1-4N0-1M0 underwent radical prostatectomy at the Cancer Center in 1997 to 2008. The median age was 60.06.4 (43-73) years. The median preoperative PSA level was 10.413.7 (0.8-95.7) ng/ml (PSA<10 ng/ml; n = 67 (46.5%), PSA ≥10 ng/ml; n = 77 (53.5%). Histological study verified adenocarcinoma in all specimens. The median Gleason score was 6.01.4 (Gleason score <7; n = 112 (77.8%), Gleason score ≥7; n = 32 (22.2%)). Extracapsular tumor extension was revealed in 47 (32.6%), seminal vesicle invasion in 13 (9.0%), regional lymph node metastases in 9 (6.3%), positive margin in 9 (6.3%), microvascular invasion in 58 (40.3%), perineural invasion in 61 (42.4%) of the 144 cases. The median follow-up was 36.615.2 months. Results: microvascular invasion was associated with an increase of Gleason score≥7 rate from 15.1 to 32.8% (p=0.015), extracapsular extension rate from 17.4 to 55.2% (p<0.0001), seminal vesicle invasion rate from 1.2 to 20.7% (p<0.0001) and category N+ rate from 3.5 to 10.3% (p=0.095). Perineural invasion was associated with an increase of extracapsular extension rate from 19.3 to 50.8% (p<0.0001) and seminal vesicle invasion rate from 0.0 to 21.3% (p<0.0001). Microvascular and perineural invasion did not influence positive margin rate (p>0.05). Prostate cancer recurrence developed in 19 (13.2%) of the 144 patients. Relapses were registered more frequently in patients with microvascular (from 8.1 to 20.7% respectively, p=0.028) and perineural (from 8.4 to 19.7% respectively; p=0.043) invasion. Five-year overall, specific and PSA recurrence-free survival in a group of 144 patients was 97.6, 98.3, and 82.1%, respectively. Microvascular invasion significantly decreased 5-year PSA recurrence-free survival from 90.0 to 66.8% (p=0.050), but this difference did not translate into a statistically significant reduction in overall (98.8 and 96.0%, respectively, p=0.812) and specific (100.0 and 96.0% respectively, p=0.251) survival. Perineural invasion was associated with a significant decrease in 5-year PSA recurrence-free survival from 92.4 to 68.2% (p=0.045). Overall (100.0% and 94.1% respectively, p=0.090) and specific (100.0% and 95.7% respectively, p=0.217) survival differences between the groups without and with perineural invasion did not reach statistical significance. Conclusion: microvascular and perineural invasion is associated with the worst pathological findings in prostatectomy specimens, higher recurrence rate and lower PSA recurrence-free survival in patients with prostate cancer pT1-4N0-1M0. |
|
Publisher |
"PH "ABV-Press"", LLC
|
|
Contributor |
—
— |
|
Date |
2014-07-24
|
|
Type |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion — — |
|
Format |
application/pdf
|
|
Identifier |
http://oncourology.abvpress.ru/index.php/oncur/article/view/15
|
|
Source |
Oncourology; № 1 (2010); 33-38
Онкоурология; № 1 (2010); 33-38 1726-9776 |
|
Language |
rus
|
|
Relation |
http://oncourology.abvpress.ru/index.php/oncur/article/view/15/30
|
|
Rights |
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договоронности, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access). |
|